14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.52 $2.23 Tuesday, 23rd Apr 2024 CYCC stock ended at $1.79. This is 2.29% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 10.12% from a day low at $1.68 to a day high of $1.85.
90 days $1.52 $3.08
52 weeks $1.52 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Aug 11, 2023 $8.45 $8.85 $7.85 $7.97 13 490
Aug 10, 2023 $9.00 $9.12 $8.25 $8.25 5 473
Aug 09, 2023 $9.38 $9.38 $8.25 $8.28 6 336
Aug 08, 2023 $9.24 $9.27 $8.70 $8.77 2 206
Aug 07, 2023 $9.45 $9.45 $8.88 $8.88 2 014
Aug 04, 2023 $9.17 $9.62 $9.17 $9.36 639
Aug 03, 2023 $9.38 $9.75 $9.17 $9.23 4 859
Aug 02, 2023 $9.21 $9.34 $9.10 $9.30 1 664
Aug 01, 2023 $9.77 $9.94 $8.55 $9.21 4 988
Jul 31, 2023 $9.45 $10.28 $9.18 $10.04 4 003
Jul 28, 2023 $10.05 $10.20 $9.47 $9.74 1 568
Jul 27, 2023 $9.59 $10.05 $9.30 $9.73 2 355
Jul 26, 2023 $9.24 $9.90 $9.00 $9.42 4 489
Jul 25, 2023 $11.25 $11.25 $9.15 $9.62 14 449
Jul 24, 2023 $11.40 $11.40 $10.50 $10.80 5 293
Jul 21, 2023 $10.90 $11.10 $10.50 $10.83 1 149
Jul 20, 2023 $11.76 $11.78 $10.20 $10.50 6 643
Jul 19, 2023 $10.88 $13.20 $10.50 $11.25 39 558
Jul 18, 2023 $9.14 $10.80 $9.14 $10.58 21 600
Jul 17, 2023 $8.85 $9.00 $8.49 $8.63 2 146
Jul 14, 2023 $8.94 $9.37 $8.61 $8.79 4 352
Jul 13, 2023 $8.96 $9.07 $8.70 $9.00 4 090
Jul 12, 2023 $8.80 $9.33 $8.33 $9.00 2 856
Jul 11, 2023 $8.40 $8.99 $8.25 $8.80 3 803
Jul 10, 2023 $8.62 $9.00 $8.40 $8.40 2 942
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT